H.B. Fuller (NYSE:FUL) Hits New 12-Month Low - Here's What Happened

H.B. Fuller (NYSE:FUL - Get Free Report)'s share price reached a new 52-week low during trading on Wednesday . The stock traded as low as $59.01 and last traded at $59.47, with a volume of 9623 shares traded. The stock had previously closed at $60.10.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the company. Citigroup decreased their price target on H.B. Fuller from $78.00 to $68.00 and set a "neutral" rating on the stock in a research note on Friday, January 3rd. Vertical Research lowered shares of H.B. Fuller from a "buy" rating to a "hold" rating in a report on Monday, January 6th. JPMorgan Chase & Co. reduced their price target on shares of H.B. Fuller from $70.00 to $60.00 and set an "underweight" rating on the stock in a research report on Friday, January 17th. Finally, Deutsche Bank Aktiengesellschaft dropped their price objective on shares of H.B. Fuller from $75.00 to $72.00 and set a "buy" rating for the company in a report on Wednesday, January 22nd. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and one has issued a buy rating to the stock. According to MarketBeat, H.B. Fuller has a consensus rating of "Hold" and an average target price of $75.60.

H.B. Fuller Stock Performance

The company has a debt-to-equity ratio of 1.10, a current ratio of 1.81 and a quick ratio of 1.16. The stock's 50 day simple moving average is $63.63 and its two-hundred day simple moving average is $73.21. The company has a market capitalization of $3.13 billion, a P/E ratio of 24.77, a P/E/G ratio of 1.13 and a beta of 1.42.

Remove Ads

H.B. Fuller (NYSE:FUL - Get Free Report) last issued its quarterly earnings results on Wednesday, January 15th. The specialty chemicals company reported $0.92 EPS for the quarter, missing the consensus estimate of $1.00 by ($0.08). The business had revenue of $923.00 million for the quarter, compared to analyst estimates of $916.84 million. H.B. Fuller had a return on equity of 12.01% and a net margin of 3.65%. The firm's quarterly revenue was up 2.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.32 EPS. As a group, research analysts expect that H.B. Fuller will post 4.07 earnings per share for the current year.

H.B. Fuller Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, February 20th. Investors of record on Thursday, February 6th were paid a dividend of $0.2225 per share. This represents a $0.89 annualized dividend and a yield of 1.56%. The ex-dividend date of this dividend was Thursday, February 6th. H.B. Fuller's payout ratio is 38.53%.

Institutional Investors Weigh In On H.B. Fuller

Large investors have recently modified their holdings of the business. Lord Abbett & CO. LLC lifted its stake in H.B. Fuller by 79.8% in the third quarter. Lord Abbett & CO. LLC now owns 730,058 shares of the specialty chemicals company's stock valued at $57,952,000 after buying an additional 324,056 shares in the last quarter. Bank of New York Mellon Corp lifted its position in H.B. Fuller by 17.2% in the 4th quarter. Bank of New York Mellon Corp now owns 554,947 shares of the specialty chemicals company's stock valued at $37,448,000 after acquiring an additional 81,558 shares in the last quarter. Amundi lifted its position in H.B. Fuller by 191.9% in the 4th quarter. Amundi now owns 28,553 shares of the specialty chemicals company's stock valued at $1,804,000 after acquiring an additional 18,771 shares in the last quarter. Geode Capital Management LLC increased its holdings in H.B. Fuller by 1.5% during the 3rd quarter. Geode Capital Management LLC now owns 1,258,752 shares of the specialty chemicals company's stock worth $99,939,000 after purchasing an additional 18,734 shares in the last quarter. Finally, Kennedy Capital Management LLC increased its holdings in H.B. Fuller by 13.4% during the 4th quarter. Kennedy Capital Management LLC now owns 127,896 shares of the specialty chemicals company's stock worth $8,630,000 after purchasing an additional 15,100 shares in the last quarter. 95.93% of the stock is currently owned by institutional investors.

About H.B. Fuller

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.